NASDAQ:MLYS

Mineralys Therapeutics Stock Insider Trading

etoro logo Buy MLYS
*Your capital is at risk
$25.61
+0.240 (+0.95%)
At Close: Jun 23, 2026

Mineralys Therapeutics Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 33.09. In total, the insiders bought 1.55M and sold 203.62K MLYS shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 100 transactions)
33.09
Buy 1.55M shares
Sell 203.62K shares
73% Buy Activity
Moderate Positive Correlation
Sell Signal Low Confidence
Nov 20, 2025

Analysis Breakdown:

  • Signal is highly questionable due to a strongly contradictory positive Insider Power Score of 33.09.
  • Partially supported by a positive historical correlation.
  • Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date Type Person Role Amount
Jun 17, 2026
Buy
Stock Option
M-Exempt
Karydas Daphne
Director
Director 3 000
Value: $36.1K
Jun 17, 2026
Buy
Common Stock
M-Exempt
Karydas Daphne
Director
Director 3 000
Value: $36.1K
Jun 17, 2026
Buy
Stock Option
M-Exempt
Rodman David Malcom
Chief Medical Officer
Officer 4 167
Value: $59.4K
Jun 17, 2026
Sell
Common Stock
S-Sale
Karydas Daphne
Director
Director 3 000
Value: $75.0K
Jun 17, 2026
Buy
Stock Option
M-Exempt
Rodman David Malcom
Chief Medical Officer
Officer 417
Value: $6K
Jun 17, 2026
Sell
Common Stock
S-Sale
Rodman David Malcom
Chief Medical Officer
Officer 4 584
Value: $114.6K
Jun 17, 2026
Buy
Common Stock
M-Exempt
Rodman David Malcom
Chief Medical Officer
Officer 4 167
Value: $59.4K
Jun 17, 2026
Buy
Common Stock
M-Exempt
Rodman David Malcom
Chief Medical Officer
Officer 417
Value: $6K
Jun 15, 2026
Buy
Stock Option
M-Exempt
Rodman David Malcom
Chief Medical Officer
Officer 3 542
Value: $36.1K
Jun 15, 2026
Sell
Common Stock
S-Sale
Rodman David Malcom
Chief Medical Officer
Officer 9 890
Value: $235.5K
Jun 15, 2026
Buy
Common Stock
M-Exempt
Rodman David Malcom
Chief Medical Officer
Officer 3 542
Value: $36.1K
Jun 12, 2026
Buy
Stock Option
M-Exempt
Rodman David Malcom
Chief Medical Officer
Officer 6 349
Value: $7K
Jun 12, 2026
Buy
Common Stock
M-Exempt
Rodman David Malcom
Chief Medical Officer
Officer 6 349
Value: $7K
Jun 12, 2026
Sell
Common Stock
S-Sale
Rodman David Malcom
Chief Medical Officer
Officer 6 349
Value: $151.9K
Jun 10, 2026
Buy
Stock Option
M-Exempt
Rodman David Malcom
Chief Medical Officer
Officer 2 170
Value: $34.7K
Jun 10, 2026
Buy
Common Stock
M-Exempt
Rodman David Malcom
Chief Medical Officer
Officer 2 170
Value: $34.7K
Jun 10, 2026
Sell
Common Stock
S-Sale
Rodman David Malcom
Chief Medical Officer
Officer 2 170
Value: $54.3K
May 18, 2026
Buy
Common Stock
M-Exempt
Rodman David Malcom
Chief Medical Officer
Officer 417
Value: $6K
May 18, 2026
Buy
Stock Option
M-Exempt
Rodman David Malcom
Chief Medical Officer
Officer 417
Value: $6K
May 18, 2026
Sell
Common Stock
S-Sale
Rodman David Malcom
Chief Medical Officer
Officer 417
Value: $11.5K
May 13, 2026
Buy
Common Stock
M-Exempt
Rodman David Malcom
Chief Medical Officer
Officer 3 541
Value: $36.1K
May 13, 2026
Sell
Common Stock
S-Sale
Rodman David Malcom
Chief Medical Officer
Officer 14 056
Value: $401.8K
May 13, 2026
Buy
Stock Option
M-Exempt
Rodman David Malcom
Chief Medical Officer
Officer 3 541
Value: $36.1K
May 13, 2026
Buy
Common Stock
M-Exempt
Rodman David Malcom
Chief Medical Officer
Officer 4 166
Value: $59.4K
May 13, 2026
Buy
Stock Option
M-Exempt
Rodman David Malcom
Chief Medical Officer
Officer 4 166
Value: $59.4K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
GOLDEN STAR
Ticker Change Signal Date
IDYA
$28.98
18.12% Jun 12
DHI
$146.71
6.39% Jun 10
E
ETD
$20.67
4.79% Jun 05
EAT
$140.46
16.94% Jun 05
TPR
$140.47
7.16% Jun 04

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE